Catalent Pharma reviews about "layoff"

Culture, layoffs, workload, the management

12 hour shifts and every other weekend micromanaging Management is horrible Massive layoffs every year

Catalent has become an extremely difficult place to work due to the complete lack of strong, consistent leadership. There is little to no clear direction from upper management, and decisions often feel reactive rather than strategic. Employees are left to navigate constant uncertainty without support, guidance, or a clear vision for the future. Layoffs have become frequent and seem to happen without transparency or accountability. Instead of addressing the root causes of operational issues, leadership often shifts blame onto employees. Teams are expected to deliver results while dealing with understaffing, unclear expectations, and constantly changing priorities. This creates an environment where employees feel disposable rather than valued. Morale across teams has suffered significantly. Many talented, hardworking individuals have been let go, while those remaining are left to carry increased workloads without recognition or reassurance. It feels like there is no stability or long-term future within the company, which makes it difficult to stay motivated or invested. What is most frustrating is the lack of ownership from leadership. Rather than acknowledging structural and organizational failures, employees are often blamed for problems that stem from poor planning, lack of communication, and inconsistent management decisions. This erodes trust and creates a culture of fear and uncertainty. Catalent has the potential to be a strong organization, but without accountable leadership, clear direction, and genuine support for employees, it continues to decline. Until leadership takes responsibility and prioritizes transparency, stability, and employee well-being, it will remain a challenging and discouraging place to work

Huge layoffs' may be an indication of problems to come

No work life balance Laid off 2/3 of employees

- The executive team consists primarily of finance professionals with limited direct experience in biopharmaceutical operations and quality systems. - Substantial debt accumulation and strategic divestitures occurred without sufficient investment in core manufacturing infrastructure or process improvements. - High employee turnover and repeated layoffs have led to increased workloads, reduced staffing levels, and declining team morale. - Persistent gaps in training, documentation, and maintenance contribute to quality deviations and regulatory compliance difficulties. - Communication between departments is often limited, resulting in unrealistic timelines and frequent project delays. - The company faced significant financial pressures approaching instability prior to the private acquisition. - Professional development opportunities are minimal, recognition is inconsistent, and work-life balance remains challenging for most roles

Horrible upper management and business development. There will most likely be layoffs in the future. You will not be promoted or get a wage adjustment for inflation.

Horrible top down, micromanagement culture. Clueless leaders who do not care about their people. Toxic behaviors from "leadership" including severe retaliation for anything and everything they view as a threat. If you're a good employee, you'll be swamped with more and more work. The company is losing great employees every day. The CEO is a bully and NEVER takes responsibility for his mistakes. Terrible pay, well below the rest of the CDMO industry. They say they have a "patient first" culture but that could not be further from the truth. The company is happy to take their clients money but ALWAYS executes poorly which is why the reputation is so horrible (check the news to see what I mean. Cat hair!!). Layoffs are constant and you'll be expected to do the job of 3-5 people.

Job stability is bad with constant layoffs